Heron Therapeutics, Inc. announced on December 23, 2024, the relocation of its corporate headquarters from San Diego, California, to Cary, North Carolina, effective January 1, 2025. This move centralizes the majority of Heron's Management Team and corporate employees, who already work from the Cary office.
The new headquarters is strategically located near the Research Triangle Park (RTP), a prominent high-tech research and development hub in the United States. This location offers ample space for growth and expansion within a thriving biotech community.
CEO Craig Collard stated that the relocation is a significant milestone, designed to strengthen the company's ability to support employees by centralizing operations and resources. The move is also expected to position Heron favorably for continued strategic partnerships as it expands its portfolio in acute and oncology care settings.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.